Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Allopurinol for Prevention of Capecitabine-induced Hand-foot Syndrome
NCT01609166Phase 2Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jul 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in hand-foot syndrome (HFS), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jul 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT01609166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609166.